LaCorium Health refreshes graphics on flagship product, Flexitol Heel Balm
WESTFIELD, N.J. — LaCorium Health, the maker of the Flexitol line of therapeutic skincare products, recently refreshed the package graphics on its flagship product, Flexitol Heel Balm for rough, dry and cracked feet.
The winning design was chosen after research showed that the new package was more visible on store shelves and better communicated the benefits of Flexitol, while staying true to the brand’s heritage.
In addition, the new package design highlights the results of a new clinical study demonstrating that most consumers will experience visible results in just one day when using Flexitol Heel Balm as directed. The new carton graphics started rolling out in late October, and all sizes will ship bearing the new look by the first quarter of 2015.
Provider tool initiates patient conversations on weight released by STOP Obesity Alliance
BOSTON — The Strategies to Overcome and Prevent (STOP) Obesity Alliance on Wednesday released a tool for healthcare providers that offers guidance and suggestions on how to initiate conversations with adult patients about weight and health. "Why Weight? A Guide to Discussing Obesity & Health With Your Patients" is a unique tool designed to help providers build a safe and trusting environment with patients to facilitate open, productive conversations about weight.
Weight is a complex and sensitive issue, and conversations surrounding the topic can be challenging. Because obesity and overweight affect two-thirds of Americans, healthcare providers increasingly are being called on to support their patients in matters dealing with weight.
Many providers have concerns about how to begin discussing weight in ways that are empowering and nonjudgmental. The tool discusses potential scenarios providers may face and suggests ways to approach the conversation.
“Research has shown that behavioral and medical treatment can be effective, but improvised and uninformed discussions may stigmatize, shame or fail to engage patients, to the detriment of the provider-patient relationship and patient outcomes,” said STOP Obesity Alliance director William Dietz. “This tool offers providers a unique and much-needed resource that can help them to facilitate conversations about weight.”
In addition to skills for building a safe, trusting environment with patients and facilitating productive conversations about weight, the guide also includes practical information on coding and patient accommodation.
STOP developed the guide using a comprehensive process that included conducting an audit of available research on provider-patient communication and consultation with a range of experts from obesity practice and research, primary care practice, nutrition education, women’s health, minority health and the patient community to offer insight based on their expertise and to guide development of the tool.
“We are thrilled to have taken part in the process to develop this tool and think it does an excellent job of responding to a real need among providers for resources to initiate these difficult conversations,” said Wendy Nickel, director, Center for Patient Partnership in Healthcare for the American College of Physicians. “It is a well-informed and valuable resource.”
Study: Calcium-collagen chelate effective in slowing bone loss
TALLAHASSEE, Fla. — A new study by a Florida State University researcher found that a new dietary supplement is superior to calcium and vitamin D when it comes to bone health.
Over 12 months, Bahram Arjmandi Margaret A. Sitton, professor in the Department of Nutrition, Food and Exercise Sciences and Director of the Center for Advancing Exercise and Nutrition Research on Aging at Florida State, studied the impact of the dietary supplement KoACT versus calcium and vitamin D on bone loss. KoACT is a calcium-collagen chelate, a compound containing calcium and collagen that are bound together.
Calcium and vitamin D are generally thought of as the first line of defense when it comes to bone health, but Arjmandi’s research found that the calcium-collagen chelate was more effective in slowing bone loss.
Arjmandi’s study is published in the most recent issue of Journal of Medicinal Food.
A group of 39 women were randomly divided into two groups, with the control group taking a capsule that was a mix of calcium and vitamin D. The other group took the calcium-collagen chelate.
The women taking the calcium-collagen chelate saw substantially less bone loss than the control group over a year’s time. The group taking the calcium-collagen chelate saw a loss of 1.2% in bone mineral density, while the control group saw a 3.8% loss.
Arjmandi’s study was funded by ingredient manufacturer AIDP, which markets KoACT.
Loading Post Please Wait...